Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward V Nunes, MD
New York State Psychiatric Institute/Columbia University Irving Medical Center
Principal Investigator - John Rotrosen, MD
NYU Langone Health
Principal Investigator - Roger Weiss, MD
Harvard Medical School/McLean Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences (uams) / Center for Addiction Services and Treatment (cast)
Little Rock, Arkansas, United States
- Tarzana Treatment Centers, Inc.
Tarzana, California, United States
- Liberation Programs, Inc.
Bridgeport, Connecticut, United States
- Operation Par
Clearwater, Florida, United States
- Gateway Community Services
Jacksonville, Florida, United States
- Aspire Health Partners
Orlando, Florida, United States
- Mountain Manor / Maryland Treatment Centers
Baltimore, Maryland, United States
- Mclean Hospital
Belmont, Massachusetts, United States
- Stanley Street Treatment and Resources, Inc.
Fall River, Massachusetts, United States
- Square Medical Group, Llc
Newton, Massachusetts, United States
- Gibson Center for Behavioral Change
Cape Girardeau, Missouri, United States
- Dartmouth Hitchcock - Atp
Lebanon, New Hampshire, United States
- University of New Mexico Addiction and Substance Abuse Program
Albuquerque, New Mexico, United States
- Bellevue Hospital Center
New York, New York, United States
- Adapt Integrated Health Care
Roseburg, Oregon, United States
- Adapt Integrated Health Care
Winston, Oregon, United States
- Center for Psychiatric and Chemical Dependency Services (cpcds)
Pittsburgh, Pennsylvania, United States
- Internal Medicine Recovery Engagement Program (im-Rep)
Pittsburgh, Pennsylvania, United States
- Shoreline Behavioral Health Services
Conway, South Carolina, United States
- Huntsman Mental Health Institute / University of Utah
Salt Lake City, Utah, United States
- Chestnut Ridge Center
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2021
- Primary completion
- 31 Dec 2026
- Completion
- 31 Jan 2027
- Last update posted
- 22 Jun 2026
- Registered enrollment
- 1,516
- Registry id
- NCT04464980
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.